Abstract
Aim
To assess the impact of oral anticoagulation (OA) on morbidity of transurethral resection of the prostate (TURP). OA included warfarin and platelet aggregation inhibitors (PAI).
Patients and Method
Multicenter analysis of patients operated for symptomatic benign prostatic hyperplasia (BPH) by TURP. Patients under OA were compared to those with no OA.
Results
Out of 612 patients included in the analysis, 206 (33%) were on OA prior surgery (55 warfarin, 142 PAI, and 9 warfarin and PAI). No patient continued warfarin and clopidogrel during the operating period. Patients under OA were significantly older (75 vs. 71 yo, P < 0.001), had larger prostate volume (56 vs. 49 ml, P = 0.05), and had higher rate of bladder catheter prior surgery (26 vs. 17%, P = 0.02). At 3 months follow-up, patients in the OA group had a higher weight of resected tissue (24 vs. 21.7 g, P < 0.001), a longer duration of hospitalization (6.4 vs. 4.7 days P < 0.001), a higher rate of bladder clots (13 vs. 4.7%, P < 0.001), red cell transfusion (1.9 vs. 1.0%, P = 0.026), late hematuria (15.0 vs. 8.4%, P = 0.004), and thromboembolic events (2.4 vs. 0.7, P = 0.02). In multivariable analysis, OA status was the sole independent parameter associated with bladder clots (P = 0.004) and with late hematuria (P = 0.03).
Conclusion
OA had a significant and independent impact on TURP outcome in terms of bleeding complications. This data could be used for treatment decision and for patient’s information prior BPH surgery.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Reich O, Gratzke C, Bachmann A et al (2008) Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10, 654 patients. J Urol 180:246–249
Borboroglu PG, Kane CJ, Ward JF, Roberts JL, Sands JP (1999) Immediate and postoperative complications of transurethral prostatectomy in the 1990 s. J Urol 162:1307–1310
Rassweiler J, Teber D, Kuntz R, Hofmann R (2006) Complications of transurethral resection of the prostate (TURP)—incidence, management, and prevention. Eur Urol 50:969–979
Kuntz RM (2007) Laser treatment of benign prostatic hyperplasia. World J Urol 25:241–247
Barmoshe S, Zlotta AR (2006) How do I treat and follow my TUNA patients. World J Urol 24:397–404
Herrmann TR, Gross AJ, Schultheiss D, Kaufmann PM, Jonas U, Burchardt M (2006) Transurethral microwave thermotherapy for the treatment of BPH: still a challenger? World J Urol 24:389–396
Descazeaud A, Robert G, Azzousi AR et al (2009) Committee for lower urinary tract symptoms of the French Association of Urology. Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review. BJU Int 103:1162–1165
Ruszat R, Wyler S, Forster T et al (2007) Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 51:1031–1038
Chakravarti A, Mawarfarinermott S (1998) Transurethral resection of the prostate in the anticoagulated patient. Br J Urol 81:520–522
Dotan ZA, Mor Y, Leibovitch I et al (2002) The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction. J Urol 168:610–613
Parr NJ, Loh CS, Desmond AD (1989) Transurethral resection of the prostate and bladder tumour without withdrawal of warfarin therapy. Br J Urol 64:623–625
Burger W, Chemnitius JM, Kneissl GD, Rücker G (2005) Low-dose aspirin for secondary cardiovascular prevention—cardiovascular risks after its perioperative withdrawal vs. bleeding risks with its continuation—review and meta-analysis. J Intern Med 257:399–414
Nielsen JD, Holm-Nielsen A, Jespersen J, Vinther CC, Settgast IW, Gram J (2000) The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy—a prospective, randomized, double-blind, placebo-controlled study. Scand J Urol Nephrol 34:194–198
Ruszat R, Wyler S, Forster T et al (2007) Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 51:1031–1038
Ehrlich Y, Yossepowitch O, Margel D, Lask D, Livne PM, Baniel J (2007) Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: a prospective, randomized trial. J Urol 178:524–528
Ten Cate H, Henny CP, ten Cate JW, Buller HR, Dabhoiwala NF (1987) Randomized double-blind, placebo controlled safety study of a low molecular weight heparinoid in patients under going transurethral resection of the prostate. Thromb Haemost 57:92–96
Lund L, Moller Ernst Jnsen K, Torring N, Erik Niesen J (2005) Impact of finasteride treatment on perioperative bleeding before transurethral resection of the prostate: a prospective randomized study. Scand J Urol Nephrol 39:160–162
Ozdal OL, Ozden C, Benli K, Gokkaya S, Bulut S, Memis A (2005) Effect of short term finasteride therapy on preoperative bleeding in patients who were candidates for transurethral resection of the prostate: a randomized controlled study. Prostate cancer Prostatic dis 8:215–218
Conflict of interest statement
No conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
From the committee for lower urinary tract symptoms of the French Association of Urology.
Rights and permissions
About this article
Cite this article
Descazeaud, A., Robert, G., Lebdai, S. et al. Impact of oral anticoagulation on morbidity of transurethral resection of the prostate. World J Urol 29, 211–216 (2011). https://doi.org/10.1007/s00345-010-0561-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-010-0561-3